Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
RESEARCH TOOLSreports
Holding CASI?
Track your performance easily
CASI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.90 - $8.48
Previous Close$6.76
Volume6.11K
Average Volume (3M)247.85K
Market Cap
$91.80M
Enterprise Value$78.72M
Total Cash (Recent Filing)$30.77M
Total Debt (Recent Filing)$18.89M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Nov 14, 2024EPS Estimate
-$0.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.02
Shares Outstanding15,460,457
10 Day Avg. Volume17,707
30 Day Avg. Volume247,855
Standard Deviation0.28
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.33
Price to Sales (P/S)3.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.31
Enterprise Value/Gross Profit3.93
Enterprise Value/Ebitda-2.88
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CASI Pharmaceuticals News
PremiumCompany Announcements
CASI Pharmaceuticals Revamps Management Structure
PremiumCompany Announcements
CASI Pharmaceuticals Shifts Focus, Garners Investment
PremiumCompany Announcements
CASI Pharmaceuticals Freezes Juventas Assets Amid DisputePremiumCompany Announcements
CASI Pharmaceuticals Welcomes New CFO
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CASI FAQ
What was CASI Pharmaceuticals’s price range in the past 12 months?
CASI Pharmaceuticals lowest stock price was $1.90 and its highest was $8.48 in the past 12 months.
What is CASI Pharmaceuticals’s market cap?
Currently, no data Available
When is CASI Pharmaceuticals’s upcoming earnings report date?
CASI Pharmaceuticals’s upcoming earnings report date is Nov 14, 2024 which is in 55 days.
How were CASI Pharmaceuticals’s earnings last quarter?
CASI Pharmaceuticals released its earnings results on Aug 16, 2024. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.63 by $0.11.
Is CASI Pharmaceuticals overvalued?
According to Wall Street analysts CASI Pharmaceuticals’s price is currently Overvalued.
Does CASI Pharmaceuticals pay dividends?
CASI Pharmaceuticals does not currently pay dividends.
What is CASI Pharmaceuticals’s EPS estimate?
CASI Pharmaceuticals’s EPS estimate is -$0.62.
How many shares outstanding does CASI Pharmaceuticals have?
CASI Pharmaceuticals has 13,401,375 shares outstanding.
What happened to CASI Pharmaceuticals’s price movement after its last earnings report?
CASI Pharmaceuticals reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.63. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CASI Pharmaceuticals?
Among the largest hedge funds holding CASI Pharmaceuticals’s share is Consonance Capital. It holds CASI Pharmaceuticals’s shares valued at N/A.
---
CASI Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
218.86%
12-Months-Change
Fundamentals
Return on Equity
-122.91%
Trailing 12-Months
Asset Growth
-31.57%
Trailing 12-Months
Company Description
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
---
CASI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CASI
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
-9.04%
reiterated a buy rating 4 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -9.04% per trade.
---